Gang Hu, MD, MPH, PhD, FAHA

Associate professor & Director, Chronic Disease Epidemiology Lab

Associate Professor

Department/Laboratory:

Phone:
(225) 763-3053
 
Fax:
(225) 763-3009
Send E-mail 
 

EDUCATION

M.D., Tianjin Medical University, Tianjin, China, 1989
M.P.H., University of Kuopio, Kuopio, Finland, 2000
Ph.D., University of Kuopio, Kuopio, Finland, 2001
Docent (Adjunct professor), University of Helsinki, Helsinki, Finland, 2005, Public Health

RESEARCH INTERESTS

Dr. Gang Hu's research interests are focused on the role of lifestyle factors, classical chronic disease risk factors, genetic factors, DNA methylomics and their interactions on the risk of several chronic diseases, including coronary heart disease, stroke, heart failure, diabetes, and cancer. Dr. Hu is collaborating with several large-scale epidemiological studies and clinical trials, including the Louisiana State University Hospital-based Longitudinal Study (LSUHLS), the FINRISK (also called FINMONICA) Study, Tianjin Children Obesity Study, Tianjin Gestational Diabetes Prevention Project, and Louisiana Experiment Assessing Diabetes outcomes (LEAD) cohort study.

Dr. Hu’s specific interests include:
1. Different kinds of physical activity (occupational, commuting, and leisure time), obesity and their combined effects on the risk of several chronic diseases (type 2 diabetes, hypertension, coronary heart disease, heart failure, stroke, and cancer);
2. Insulin resistance, glucose tolerance, the metabolic syndrome and the risks of type 2 diabetes and cardiovascular disease;
3. Classical vascular risk factors and medicine treatments on the risks of cardiovascular disease and cancer among diabetic patients;
4. Coffee and alcohol consumption and the risk of several chronic diseases;
5). Dietary factors and the risk of several chronic diseases;
6). The interaction in lifestyle and genetic/epigenetic factors on the risk of type 2 diabetes in women with gestational diabetes.

SELECTED PUBLICATIONS

10 most important articles from 300 publications.
More publications, please see http://labs.pbrc.edu/chronicdisease/publications.htm

1. Hu G, Eriksson JG, Barengo NC, Lakka TA, Valle TT, Nissinen A, Jousilahti P, Tuomilehto J. Occupational, commuting, and leisure time physical activity in relation to total and cardiovascular mortality among Finnish subjects with type 2 diabetes. Circulation 2004; 110: 666-673.

2. Hu G, Qiao Q, Tuomilehto J. Balkau B, Borch-Johnsen K, Pyörälä K for the DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Archive of Internal Medicine 2004; 164: 1066-1076.

3. Hu G, Jousilahti P, Qiao Q, Peltonen M, Katoh S, Tuomilehto J The impact of diabetes and myocardial infarction at baseline and during follow-up on cardiovascular mortality. Journal of the American College of Cardiology 2005; 45: 1413-1418.

4. Hu G, Jousilahti P, Borodulin K, Tuomilehto J. The joint associations of occupational, commuting, and leisure-time physical activity, and the Framingham risk score on the 10-year risk of coronary heart disease. European Heart Journal 2007; 28: 492-498.

5. Wang Y, Tuomilehto J, Jousilahti P, Antikainen R, Mähönen M, Katzmarzyk PT, Hu G. Occupational, commuting and leisure-time physical activity in relation to heart failure among Finnish men and women. Journal of the American College of Cardiology 2010; 56: 1140-1148.

6. Zhang Y, Tuomilehto J, Jousilahti P, Wang Y, Antikainen R, Hu G. Lifestyle Factors on the Risks of Ischemic and Hemorrhagic Stroke. Archive of Internal Medicine 2011; 171: 1811-1818.

7. Zhao W, Katzmarzyk PT, Horswell R, Li W, Wang Y, Johnson J, Heymsfield SB, Cefalu WT, Ryan DH, Hu G. Body mass index and the risk of all-cause mortality among patients with type 2 diabetes mellitus. Circulation 2014; 130: 2143-2151.

8. Zhao P, Liu E, Qiao Y, Katzmarzyk PT, Chaput JP, Fogelholm M, Johnson WD, Kuriyan R, Kurpad A, Lambert EV, Maher C, Maia J, Matsudo V, Olds T, Onywera V, Sarmiento OL, Standage M, Tremblay MS, Tudor-Locke C, Hu G. Maternal gestational diabetes and childhood obesity at age 9-11: results of a multinational study. Diabetologia 2016; 59: 2339-2348.

9. Wang T, Liu H, Wang L, Huang T, Li W, Zheng Y, Heianza Y, Sun D, Leng J, Zhang S, Li N, Hu G, Qi L. Zinc-associated variant in SLC30A8 gene interacts with gestational weight gain on postpartum glycemic changes: a longitudinal study in women with prior gestational diabetes. Diabetes 2016; 65: 3786-3793.

10. Liu H, Wang L, Zhang S, Leng J, Li N, Li W, Wang J, Tian H, Qi L, Yang X, Yu Z, Tuomilehto J, Hu G. One-year weight losses in the Tianjin Gestational Diabetes Mellitus Prevention Program: A randomized clinical trial. Diabetes, Obesity and Metabolism 2018; 20: 1246-1255. ^ top